Navigation Links
AAOS Issues New Treatment Guidelines for Carpal Tunnel Syndrome
Date:10/27/2008

ROSEMONT, Ill., Oct. 27 /PRNewswire-USNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) has approved and released an evidence-based clinical practice guideline on "The Treatment of Carpal Tunnel Syndrome."

"Carpal Tunnel Syndrome, otherwise known as CTS, is among the most common disorders of the upper extremity. It affects up to ten percent of the population and is related to many factors, but is thought to be caused by increased pressure on the median nerve in the carpal tunnel in the wrist," said Michael Keith, M.D., Chair of the AAOS work group responsible for creating the new guideline.

-- According to the National Center for Health Statistics, in 2005, an

estimated 3.1 million people sought help from physicians for the

treatment of CTS.

"The Academy created this clinical practice guideline to improve patient care for those suffering from Carpal Tunnel Syndrome," stated Dr. Keith. "The document serves as a point of reference and educational tool for both family practitioners and orthopaedic surgeons, streamlining possible treatment processes for this ever-so common ailment."

In June 2007, the Journal of the Academy of Orthopaedic Surgeons (JAAOS) reported about 500,000 CTS surgical procedures are performed each year. The same study also reported the economic impact due to CTS is estimated to exceed $2 billion annually.

The final CTS Treatment guideline contains nine recommendations which include both operative and non-operative treatment options as well as alternative techniques. Some of the recommendations include:

-- Traditional bracing or splinting

-- Local steroid injection

-- Oral steroids

-- Ultrasound

-- Carpal tunnel release surgery

After doing a thorough analysis of the current literature, the work group found no evidence that supports the following treatments:

-- Heat therapy

-- Acupuncture

-- Diuretics

-- Electric stimulation

-- Massage therapy

-- Magnet therapy

-- Nutritional supplements

"This guideline is not intended to stand alone," added Dr. Keith. "It can be used as a starting point for physicians and can open up the lines of patient-physician communication on possible treatment options."

As new research, knowledge and literature on CTS becomes available, this guideline will be reviewed and re-evaluated by the Guidelines and Technology Oversight Committee. It will be considered for updating in three to five years, which is consistent with evidence-based standards.

The AAOS has released other evidence-based guidelines on musculoskeletal topics, including:

-- Diagnosis of Carpal Tunnel Syndrome

-- Prevention of Symptomatic Pulmonary Embolism (PE).

This guideline, which is aimed towards the treatment of Carpal Tunnel Syndrome in adults, was developed by an AAOS physician volunteer work group and was based upon a systematic review of the current scientific and clinical information on accepted approaches to treatment and/or diagnosis. The entire process from beginning to end lasted about eighteen months and included a review panel consisting of internal and external committees, public commentaries and final approval by the AAOS Board of Directors.

The full guideline along with all supporting documentation is available on the AAOS website: http://www.aaos.org/guidelines

http://www.orthoinfo.org

About AAOS


'/>"/>
SOURCE American Academy of Orthopaedic Surgeons
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues
2. PowerBar Issues Open Call for 2008-2009 PowerBar Team Elite(TM) Athlete Sponsorship Program
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. American Red Cross Issues Blood Supply Alert
5. OSHA Issues Draft Ergonomics Guidelines on Preventing Musculoskeletal Injuries in Shipyards
6. New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
7. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
8. Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
9. Dallas-Area Transplant Meeting Puts Spotlight on Key Issues
10. Elder Care Author Doctor Marion Launches Second National Tour to Raise Awareness About Aging & Elder Care Issues in America
11. California State PTA Issues Statement Regarding Presidents Veto of SCHIP Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD ... dose required and providing a CBD form that can be easily incorporated into liquid ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... ... ... Planet Fitness, one of the largest and fastest growing franchisors and operators ... location in Covington, LA at 401 N. U.S. Highway 190, in January of 2018. ... in the Holiday Square shopping center. Its location allows it to serve both Covington ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical ... the company with their  2017 New Product Innovation Award ... on extensive primary and secondary medical device market research by ... through its first-to-market OTC, drug-free pain relief product, the AVACEN ... approach to treating fibromyalgia widespread pain. ...
(Date:10/12/2017)... -- West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today announced that it will release third-quarter 2017 ... 26, 2017, and will follow with a conference call ... a.m. Eastern Time. To participate on the call, please ... is 94093362. A ...
(Date:10/11/2017)...  Caris Life Sciences ® , a leading innovator ... precision medicine, today announced that St. Jude Medical Center,s ... (POA) as its 17 th member. Through participation ... Cancer Institute will help develop standards of care and ... making cancer treatment more precise and effective. ...
Breaking Medicine Technology: